1,683
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Insulin resistance biomarkers in small-for-gestational-age infants born to mothers with gestational diabetes mellitus

, , , , , & show all
Pages 9061-9065 | Received 12 Dec 2020, Accepted 30 Nov 2021, Published online: 16 Dec 2021

References

  • Nicholas LM, Morrison JL, Rattanatray L, et al. The early origins of obesity and insulin resistance: timing, programming and mechanisms. Int J Obes (Lond). 2016; 40(2):229–238.
  • Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ. 2017; 356:j1.
  • Segovia SA, Vickers MH, Reynolds CM. The impact of maternal obesity on inflammatory processes and consequences for later offspring health outcomes. J Dev Orig Health Dis. 2017;8(5):529–540.
  • Darendeliler F. IUGR: genetic influences, metabolic problems, environmental associations/triggers, current and future management. Best Pract Res Clin Endocrinol Metab. 2019;33(3):101260.
  • Abokaf H, Shoham-Vardi I, Sergienko R, et al. In utero exposure to gestational diabetes mellitus and long term endocrine morbidity of the offspring. Diabetes Res Clin Pract. 2018;144:231–235.
  • Esakoff TF, Guillet A, Caughey AB. Does small for gestational age worsen outcomes in gestational diabetics? J Matern Fetal Neonatal Med. 2017;30(8):890–893.
  • Neimark E, Wainstock T, Sheiner E, et al. Long-term cardiovascular hospitalizations of small for gestational age (SGA) offspring born to women with and without gestational diabetes mellitus (GDM). Gynecol Endocrinol. 2019;35(6):518–524.
  • Silva AL, Amaral AR, Oliveira DS, et al. Neonatal outcomes according to different therapies for gestational diabetes mellitus. J Pediatr (Rio J). 2017;93(1):87–93.
  • Siddiqui S, Waghdhare S, Jha S, et al. Role of immunological markers in gestational diabetes mellitus-a brief review. Diabetes Metab Syndr. 2019;13(5):2983–2985.
  • Meyer DM, Brei C, Stecher L, et al. Maternal insulin resistance, triglycerides and cord blood insulin are not determinants of offspring growth and adiposity up to 5 years: a follow-up study. Diabet Med. 2018;35(10):1399–1403.
  • Zhang DL, Du Q, Djemli A, et al. Cord blood insulin, IGF-I, IGF-II, leptin, adiponectin and ghrelin, and their associations with insulin sensitivity, β-cell function and adiposity in infancy. Diabet Med. 2018;35(10):1412–1419.
  • International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682.
  • MOH of the PRC. The growth reference standard of Chinese children under 7 years (in Chinese). Beijing, China: The Ministry of Health of the People’s Republic of China; 2009.
  • Reinehr T, Roth CL. Inflammation markers in type 2 diabetes and the metabolic syndrome in the pediatric population. Curr Diab Rep. 2018;18(12):131.
  • Chiavaroli V, Giannini C, D’Adamo E, et al. Insulin resistance and oxidative stress in children born small and large for gestational age. Pediatrics. 2009;124(2):695–702.
  • Kanai Y, Kamoda T, Saito M, et al. Cord blood insulin-like growth factor (IGF)-1, IGF-binding proteins and adiponectin, and birth size in offspring of women with mild gestational diabetes. Early Hum Dev. 2016;93:39–42.
  • Lindsay RS, Westgate JA, Beattie J, et al. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes. Clin Endocrinol (Oxf). 2007;66(3):322–328.
  • Feng YM, Zhao D, Zhang N, et al. Insulin resistance in relation to lipids and inflammation in type-2 diabetic patients and Non-Diabetic people. PLoS One. 2016;11(4):e0153171.
  • Salis ER, Reith DM, Wheeler BJ, et al. Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates. Arch Dis Child Fetal Neonatal Ed. 2017;102(2):F162–F166.
  • Wang G, Divall S, Radovick S, et al. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA. 2014;311(6):587–596.
  • Dizdarer C, Korkmaz HA, Büyükocak ÖM, et al. Impact of insulin resistance on insulin-like growth factor-1/insulin like growth factor-binding protein-3 axis and on early weight gain in small for gestational age infants. J Clin Res Pediatr Endocrinol. 2013;5(2):104–109.
  • de Zegher F, Malpique R, Garcia-Beltran C, et al. Towards a simple marker of hepato-visceral adiposity and insulin resistance: the Z-score change from weight-at-birth to BMI-in-childhood. Pediatr Obes. 2019;14(10):e12533.
  • Vaverková H, Karásek D, Halenka M, et al. Inverse association of lipoprotein (a) with markers of insulin resistance in dyslipidemic subjects. Physiol Res. 2017; 66(1):S113–S120.
  • Newsome P, Francque S, Harrison S, et al. Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. Aliment Pharmacol Ther. 2019;50(2):193–203.
  • Eun KK, Sun HJ, Sol H, et al. Blood concentrations of lipopolysaccharide-binding protein, high-sensitivity C-reactive protein, tumor necrosis factor-α, and interleukin-6 in relation to insulin resistance in young adolescents. Clin Chim Acta. 2018;486:115–121.
  • Park SE, Park CY, Sweeney G. Biomarkers of insulin sensitivity and insulin resistance: past, present and future. Crit Rev Clin Lab Sci. 2015;52(4):180–190.
  • Aly H, Soliman RM, El-Dib M, et al. Birth weight, insulin resistance, and blood pressure in late preterm infants. Am J Perinatol. 2015;32(9):865–872.
  • Sreckovic I, Birner-Gruenberger R, Besenboeck C, et al. Gestational diabetes mellitus modulates neonatal high-density lipoprotein composition and its functional heterogeneity. Biochim Biophys Acta. 2014;1841(11):1619–1627.
  • Borgoño CA, Hamilton JK, Ye C, et al. Determinants of insulin resistance in infants at age 1 year: impact of gestational diabetes mellitus. Diabetes Care. 2012;35(8):1795–1797.
  • Leunissen RW, Kerkhof GF, Stijnen T, et al. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA. 2009;301(21):2234–2242.
  • Singhal A, Cole TJ, Fewtrell M, et al. Promotion of faster weight gain in infants born small for gestational age: is there an adverse effect on later blood pressure? Circulation. 2007;115(2):213–220.
  • Ekelund U, Ong KK, Linne Y, et al. Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab. 2007;92(1):98–103.